Responses
Scientific Abstracts
Poster Presentations
Posters
Scleroderma, myositis and related syndromes – etiology, pathogenesis and animal models
SAT0025 Antifibrotic effects of imatinib mesylate are not superior to selective inhibition of PDGFR by ARRY-768 in preclinical models of dermal fibrosis
Compose a Response to This Article
Other responses
No responses have been published for this article.